[1] Godier A,Albaladejo P,On Perioperative Haemostasis Gihp Group T F W G. Management of bleeding events associated with antiplatelet therapy: evidence, uncertainties and pitfalls[J]. J Clin Med,2020,9(7):2318. [2] Lupi S M,Rodriguez Y Baena A. Patients taking direct oral anticoagulants (DOAC) undergoing oral surgery: a review of the literature and a proposal of a peri-operative management protocol[J]. Healthcare (Basel), 2020,8(3):281. [3] Bos S,van den Boom B,Ow T W,et al. Efficacy of pro- and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery[J]. J Thromb Haemost, 2020,18(11):2840-2851. [4] Long B,Long D A,Koyfman A.Emergency medicine misconceptions: Utility of routine coagulation panels in the emergency department setting[J]. Am J Emerg Med, 2020,38(6):1226-1232. [5] Yoon U,Lai M,Nguyen T,et al.Perioperative viscoelastic assay use for monitoring coagulation among US liver transplantation centers[J]. Transplant Proc,2021,53(7): 2312-2317. [6] Xing F,Chen W,Long C,et al.Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: A systematic review and meta-analysis[J]. Orthop Traumatol Surg Res,2020,106(1):117-126. [7] Li S,Xing F,Cen Y,et al.The efficacy and safety of Epsilon-aminocaproic acid for perioperative blood management in spinal fusion surgery: a systematic review and meta-analysis[J]. World Neurosurg,2021,156: 12-21. [8] Swaminathan N,Thatcher C,Staber J M.Haemostatic efficacy of single-dose factor administration in neonates with severe haemophilia undergoing circumcision[J]. Haemophilia,2020,26(5):786-792. [9] 《围手术期出凝血管理麻醉专家意见(版)》工作组. 围手术期出凝血管理麻醉专家意见(2026版)[J]. 中华麻醉学杂志,2026,46(1):79-93. [10] Hohenberger C,Zeman F,Höhne J,et al.Symptomatic postoperative spinal epidural hematoma after spinal decompression surgery: prevalence,risk factors,and functional outcome[J]. J Neurol Surg A Cent Eur Neurosurg,2020,81(4):290-296. [11] De Vriese A S,Heine G. Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion[J]. Nephrol Dial Transplant,2022,37(11): 2072-2079. [12] 中华医学会骨科学分会创伤骨科学组,中华医学会骨科学分会外固定与肢体重建学组,中国医师协会骨科医师分会创伤专家工作委员会,等. 中国创伤骨科患者围手术期静脉血栓栓塞症预防指南(2021)[J]. 中华创伤骨科杂志,2021,23(3):185-192. [13] Labianca A,Bosetti T,Indini A,et al.Risk prediction and new prophylaxis strategies for thromboembolism in cancer[J]. Cancers,2020,12(8):2070. [14] Trabulsi N,Khafagy A M,Alhazmi L S,et al.Caprini versus Padua venous thromboembolism risk assessment scores: A comparative study in hospitalized patients at a tertiary center[J]. Saudi Med J,2024,45(4):362-368. [15] Iaccarino C,Carretta A,Demetriades A K,et al.Management of antithrombotic drugs in patients with isolated traumatic brain injury: an intersociety consensus document[J]. Neurocrit Care,2024,40(1):314-327. [16] Manchikanti L,Sanapati M R,Pampati V,et al.Updated assessment of practice patterns of perioperative management of antiplatelet and anticoagulant therapy in interventional pain management[J]. Pain Physician,2024, 27(S6):S95-S114. [17] Tomaselli G F,Mahaffey K W,Cuker A,et al.2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American college of cardiology solution set oversight committee[J]. J Am Coll Cardiol,2020,76(5):594-622. [18] 李松南,张景瑞,李昌义,等. 依达赛珠单抗对口服达比加群的心房颤动患者导管消融围术期合并症的处理[J]. 中华心血管病杂志,2021,49(3):217-223. [19] Kumbhani D J,Gibson C M,Kinlay S,et al.Antiplatelet therapy in the management of atherosclerotic cardiovascular disease: 2026 ACC scientific statement: a report of the American college of cardiology[J]. J Am Coll Cardiol,2026,88(11):1284-1313. [20] Jin H,Song J F,Shen X Y,et al.Multiple genetic mutations increase the risk of thrombosis associated with clopidogrel after percutaneous coronary intervention[J]. Pharmacogenomics,2023,24(4):227-237. [21] Patel S M,Giugliano R P,Morrow D A,et al.Long-acting factor XI inhibition and periprocedural bleeding: an analysis from AZALEA-TIMI 71[J]. J Am Coll Cardiol, 2025,85(23):2288-2298. [22] Godoy A,Grewal T S,Bhagirath V,et al.Perioperative heparin bridging in patients with mechanical aortic valves undergoing elective surgery: the AMBER study[J]. JACC Adv,2026,5(2):102578. [23] Nagami Y,Sakai T S,Yamamura M,et al.Continuous warfarin administration versus heparin bridging therapy in post colorectal polypectomy haemorrhage: a study protocol for a multicentre randomised controlled trial (WHICH study)[J]. Trials,2021,22(1):33. [24] Cosmi B.An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis[J]. Expert Opin Pharmacother,2021,22(5):583-594. [25] Vlot E A,Van den Dool E J,Hackeng C M,et al. Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit[J]. Thromb Res,2020,196:1-3. [26] Kovacs M J,Wells P S,Anderson D R,et al.Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial[J]. BMJ,2021,373:n1205. [27] Lyons M D,Pope B,Alexander J.Perioperative management of antithrombotic therapy[J]. JAMA,2024,332(5):420. [28] Xu Z L,Cao H,Sun D W,et al.Critical trigger thresholds for hemostatic management: a narrative review of viscoelastic hemostatic assay applications[J]. Front Med,2025,12:1658845. [29] Casselman F P A,Lance M D,Ahmed A,et al.2024 EACTS/EACTAIC Guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP[J]. Eur J Cardio Thorac Surg,2025,67(5):ezae352. [30] Tanaka K A,Henderson R A,Strauss E R.Evolution of viscoelastic coagulation testing[J]. Expert Rev Hematol, 2020,13(7):697-707. [31] Lin Z C,Sun H,Li D,et al.Thrombin antithrombin complex concentration as an early predictor of deep vein thrombosis after total hip arthroplasty and total knee arthroplasty[J]. BMC Musculoskelet Disord,2022,23(1):574. [32] Wang L L,Zhong J M,Xiao D,et al.Thrombomodulin (TM),thrombin-antithrombin complex (TAT),plasmin-α2-plasmininhibitor complex (PIC),and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study[J]. Ann Transl Med, 2022,10(23):1273. [33] Ji F,Qian B B,Tao J Y,et al.Trimester-specific reference intervals for coagulation biomarkers (TAT,PIC,TM, tPAI-C) and their clinical associations in healthy Chinese pregnant women[J]. Sci Rep,2026.doi: 10.1038/s41598-026-61568-6. [34] Minoza K G,Brito A M,Loss L,et al.Association between coagulation biomarkers,intracranial hemorrhage types,and tranexamic acid treatments in early traumatic brain injury[J]. J Trauma Acute Care Surg,2025,99(3): 468-476. [35] Bai H,Shen L,Zhang H L,et al.Clinical value of TAT,PIC and t-PAIC as predictive markers for severe sepsis in pediatric patients[J]. Front Pediatr,2024,12:1336583. [36] Meneses E,Boneva D,McKenney M,et al. Massive transfusion protocol in adult trauma population[J]. Am J Emerg Med,2020,38(12):2661-2666. [37] Erdoes G,Koster A,Meesters M I,et al.The role of fibrinogen and fibrinogen concentrate in cardiac surgery: an international consensus statement from the Haemostasis and Transfusion Scientific Subcommittee of the European Association of Cardiothoracic Anaesthesiology[J]. Anaesthesia,2019,74(12):1589-1600. [38] Nascimento B,Goodnough L T,Levy J H.Cryoprecipitate therapy[J]. Br J Anaesth,2014,113(6):922-934. [39] Obaid O,Anand T,Nelson A,et al.Fibrinogen supplementation for the trauma patient: Should you choose fibrinogen concentrate over cryoprecipitate?[J]. J Trauma Acute Care Surg,2022,93(4):453-460. [40] CRASH-2 trial collaborators,Shakur H,Roberts I,Bautista R,et al. Effects of tranexamic acid on death,vascular occlusive events,and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial[J]. Lancet,2010,376(9734):23-32. [41] Du W B,Zhai X J,Li Y. Bleeding control in severe spinal deformity correction surgery: the use of tranexamic acid combined with desmopressin[J]. J Surg Case Rep,2025, 2025(4):rjaf245. [42] Babu M J,Neema P K,Reazaul Karim H M,et al. Effect of two different tranexamic acid doses on blood loss in head and neck cancer surgery: a randomized,double-blind,controlled study[J]. Cureus,2021,13(12):e20190. [43] Keshavarz H,Lin W W C,Dodd S,et al. Effectiveness and safety of topically applied tranexamic acid with epinephrine in surgical procedures: a systematic review[J]. Eur Burn J,2025,6(3):52. [44] van Haeren M M T,Bozic C,Breel J S,et al. Intraoperative hemostatic agents in thoracic aortic surgery-a scoping review[J]. J Clin Med,2025,14(11):4001. [45] Puchstein D,Kork F,Schöchl H,et al.3-factor versus 4-factor prothrombin complex concentrates for the reversal of vitamin K antagonist-associated coagulopathy: a systematic review and meta-analysis[J]. Thromb Haemost, 2023,123(1):40-53. [46] Shaw J R,Gray H,Xu Y,et al.Effect of PCC on thrombin generation in patients on FXaI with bleeding or needing urgent surgery (GAUGE)[J]. Blood Adv,2026,10(15): 5378-5388. [47] Bai C B,Miao Z P,Yuan M T,et al.Peptide/doxorubicin co-assembled hydrogel for hemostatic control and sustained local chemotherapy after tumor surgery[J]. Mol Pharm,2026,23(2):916-931. [48] Peng W,Jiang Y F,Zhang Y,et al.AA/MA/AMA copolymer and chitosan as self-gelling powders for rapid hemostasis and robust tissue adhesion[J]. Int J Biol Macromol,2025,310(Pt 4):143443. [49] Fang Y J,Mu L X,Lu Y W,et al.Coagulation-independent hemostasis through architecturally programmed chitosan aerogels with dual-crosslinked networks[J]. Adv Mater, 2026,38(22):e23140. [50] Sakamoto K,Ishihara M,Kato H,et al.Andexanet Alfa for life-threatening bleeding following factor xa inhibitor treatment: postmarketing surveillance study in Japan[J]. JACC Asia,2026,6(5):651-661. [51] Rocca B,Ten Cate H.Antidotes for anticoagulation reversal[J]. N Engl J Med,2026,394(22):2235-2254. [52] Yao Y T,He L X,Tan J C.The effect of tranexamic acid on the values of activated clotting time in patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis[J]. J Clin Anesth, 2020,67:110020. [53] Fenger-Eriksen C,Kamphuisen P W,Verhamme P, et al.European guidelines on peri-operative venous thromboembolism prophylaxis: first update.: Chapter 5: Mechanical prophylaxis[J]. Eur J Anaesthesiol,2024, 41(8):589-593. [54] Xu J,Kanagaratnam A,Cao J Y,et al.A comparison of aspirin against rivaroxaban for venous thromboembolism prophylaxis after hip or knee arthroplasty: A meta-analysis[J]. J Orthop Surg (Hong Kong),2020,28(1): 2309499019896024. [55] Mikhail C,Pennington Z,Arnold P M,et al.Minimizing blood loss in spine surgery[J]. Global Spine J,2020, 10(1 Suppl):71S-83S. [56] Dong C,Li Y,Ma MD Z.Venous thromboembolism prophylaxis after spontaneous intracerebral hemorrhage: a review[J]. Neurologist,2024,29(1):54-58. [57] Qin S R,Guo S T,Yao Y C,et al.Comparison of efficacy and safety of thrombus prevention strategies after abdominal and pelvic cancer surgery: Bayesian network based meta-analysis[J]. Front Oncol,2025,15:1445485. [58] Zhang C,Bews K,Klemen N D,et al.Thrombotic and hemorrhagic outcomes after elective surgery in preoperatively anticoagulated patients[J]. Mayo Clinic Proc,2024,99(7):1038-1045. [59] Naylor R M,Dodin R E,Henry K A,et al.Timing of restarting anticoagulation and antiplatelet therapies after traumatic subdural hematoma-a single institution experience[J]. World Neurosurg,2021,150:e203-e208. [60] Albini A,Malavasi V L,Vitolo M,et al.Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis[J]. Eur J Intern Med,2021,85:27-33. [61] Zhou H J,Tang Y Y,Zhang Y T,et al.Case report on postoperative coagulation abnormalities[J]. Medicine, 2024,103(1):e36618. |